DOI: http://dx.doi.org/10.18203/2349-3933.ijam20162515

Bacteriological profile and antibiotic sensitivity pattern in sputum culture of chronic obstructive pulmonary disease patients

Shashibhushan B. L., Nagaraja C., Arun B. J., Niranjan Nagaraj

Abstract


Background: Chronic obstructive pulmonary disease (COPD) is a common disease characterized by persistent airflow obstruction with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. The aim of the present study was to obtain comprehensive insight into the bacteriological profile and antibiotic sensitivity pattern in sputum culture of COPD patients.

Methods: A retrospective observational study was carried out at Bangalore medical college, Bangalore which comprised of 100 patients diagnosed with chronic obstructive pulmonary disease from June 2015 to July 2015. Sputum culture and sensitivity reports were retrospectively analysed for the bacteriological profile and their antimicrobial sensitivity pattern.

Results: Hundred patients diagnosed with COPD included with the age group comprising from 40 to >80 years of age, most common pathogenic bacteria isolated was Streptococcus pneumonia (42%), followed by Pseudomonas aerogionsa (23%), Klebsiella (15%), E coli (12%), GNNF (7%) and citorbacter (1%). Ceftriaxone was the most effective antibiotic against Streptococcus pneumonia.

Conclusions: Streptococcus pneumoniae was the most common pathogen in COPD patients, and ceftriaxone was most effective antibiotic against the most of the organism. Ceftriaxone should be the first line empirical antibiotic.


Keywords


COPD, Bacteriological, Sputum culture, Antibiotic

Full Text:

PDF

References


Global initiative for chronic obstructive lung disease (GOLD) Global strategy for the diagnosis, management, and prevention of COPD. 2011.

Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(52):398-401.

Mannino DM. COPD Epidemiology, prevalence, morbidity and mortality and disease heterogeneity. Chest. 2002;121(5):121-6.

Chawla K, Mukhopadhay C, Majumdar M, Bairy I. Bacteriological profile and their antibiogram from cases of acute exacerbations of chronic obstructive pulmonary disease: A hospital based study. Journal of Clinical and Diagnostic Research. 2008;2:612-6.

Adams SG, Melo J, Luther MS, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000;117:1345-52.

Miravitlles M, Mayordomo C, Artes M, Sanchez-Agudo L, Nicolau F, Segu JL. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med. 1999;93:173-9.

Rennard SI, Farmer SG. Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease. Proc Am Thorac soc. 2004;1:88-92.

Shahnawaz A, Saleem SM, Bhat MA, Bhat G, Dhobi GN. Bacteriological profile in acute exacerbation of chronic obstructive pulmonary disease (COPD). JK Practitioner 2003;10:185-7.

Madhavi S, Ramarao MV, Janardhanrao R. Bacterial etiology of acute exacerbations of chronic obstructive pulmonary disease. Journal of Microbiology and Biotechnology Research. 2012;2:440-4.

Patel AK, Luhadia AS, Luhadia SK. Sputum Bacteriology and Antibiotic Sensitivity Pattern of Patients Having Acute Exacerbation of COPD in India – A Preliminary Study. J Pulm Respir Med. 2015;5:238.